Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas;
Department of Surgery, University of Texas Medical Branch, Galveston, Texas;
Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G533-49. doi: 10.1152/ajpgi.00428.2013. Epub 2014 Jul 17.
Pancreatitis is a necroinflammatory disease with acute and chronic manifestations. Accumulated damage incurred during repeated bouts of acute pancreatitis (AP) can lead to chronic pancreatitis (CP). Pancreatic parathyroid hormone-related protein (PTHrP) levels are elevated in a mouse model of cerulein-induced AP. Here, we show elevated PTHrP levels in mouse models of pancreatitis induced by chronic cerulein administration and pancreatic duct ligation. Because acinar cells play a major role in the pathophysiology of pancreatitis, mice with acinar cell-specific targeted disruption of the Pthrp gene (PTHrP(Δacinar)) were generated to assess the role of acinar cell-secreted PTHrP in pancreatitis. These mice were generated using Cre-LoxP technology and the acinar cell-specific elastase promoter. PTHrP(Δacinar) exerted protective effects in cerulein and pancreatic duct ligation models, evident as decreased edema, histological damage, amylase secretion, pancreatic stellate cell (PSC) activation, and extracellular matrix deposition. Treating acinar cells in vitro with cerulein increased IL-6 expression and NF-κB activity; these effects were attenuated in PTHrP(Δacinar) cells, as were the cerulein- and carbachol-induced elevations in amylase secretion. The cerulein-induced upregulation of procollagen I expression was lost in PSCs from PTHrP(Δacinar) mice. PTHrP immunostaining was elevated in human CP sections. The cerulein-induced upregulation of IL-6 and ICAM-1 (human acinar cells) and procollagen I (human PSCs) was suppressed by pretreatment with the PTH1R antagonist, PTHrP (7-34). These findings establish PTHrP as a novel mediator of inflammation and fibrosis associated with CP. Acinar cell-secreted PTHrP modulates acinar cell function via its effects on proinflammatory cytokine release and functions via a paracrine pathway to activate PSCs.
胰腺炎是一种具有急性和慢性表现的坏死性炎症性疾病。在反复发生的急性胰腺炎(AP)发作过程中累积的损伤可导致慢性胰腺炎(CP)。在胆胰管结扎诱导的 CP 动物模型中,胰腺甲状旁腺激素相关蛋白(PTHrP)水平升高。在这里,我们在慢性胆胰管结扎和胆胰管结扎诱导的胰腺炎动物模型中显示 PTHrP 水平升高。由于腺泡细胞在胰腺炎的病理生理学中起主要作用,因此生成了具有腺泡细胞特异性靶向破坏 Pthrp 基因(PTHrP(Δacinar))的小鼠,以评估腺泡细胞分泌的 PTHrP 在胰腺炎中的作用。这些小鼠是使用 Cre-LoxP 技术和腺泡细胞特异性弹性蛋白酶启动子生成的。PTHrP(Δacinar)在胆酸钠和胰腺导管结扎模型中发挥保护作用,表现为水肿、组织学损伤、淀粉酶分泌、胰腺星状细胞(PSC)激活和细胞外基质沉积减少。用胆酸钠体外处理腺泡细胞会增加 IL-6 表达和 NF-κB 活性;在 PTHrP(Δacinar)细胞中,这些作用减弱,同时胆酸钠和卡巴胆碱诱导的淀粉酶分泌增加也减弱。在来自 PTHrP(Δacinar)小鼠的 PSCs 中,胆酸钠诱导的前胶原 I 表达上调消失。在人类 CP 切片中 PTHrP 免疫染色增加。用 PTH1R 拮抗剂 PTHrP (7-34)预处理可抑制胆酸钠诱导的 IL-6 和 ICAM-1(人腺泡细胞)和前胶原 I(人 PSCs)的上调。这些发现确立了 PTHrP 作为与 CP 相关的炎症和纤维化的新介质。腺泡细胞分泌的 PTHrP 通过其对前炎症细胞因子释放的作用以及通过旁分泌途径激活 PSCs 的作用来调节腺泡细胞功能。